Literature DB >> 9210356

Prognostic factors in thyroid carcinoma.

P A Treseler1, O H Clark.   

Abstract

Thyroid carcinomas range from the most indolent to the most aggressive human malignancies. A variety of clinical and pathologic factors can be used to help predict behavior and determine appropriate therapy. New molecular biologic techniques show promise in further refining the assessment of prognosis in thyroid cancer patients.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9210356

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN： 1055-3207            Impact factor:   3.495


  11 in total

1.  Quantitative high-throughput drug screening identifies novel classes of drugs with anticancer activity in thyroid cancer cells: opportunities for repurposing.

Authors:  Lisa Zhang; Mei He; Yaqin Zhang; Naris Nilubol; Min Shen; Electron Kebebew
Journal:  J Clin Endocrinol Metab       Date:  2011-12-14       Impact factor: 5.958

2.  Prognostic factors for sporadic medullary thyroid carcinoma.

Authors:  Kaptan Gülben; Uğur Berberoğlu; Mustafa Boyabatli
Journal:  World J Surg       Date:  2006-01       Impact factor: 3.352

Review 3.  The role of immunohistochemical markers in the diagnosis of follicular-patterned lesions of the thyroid.

Authors:  Sylvia L Asa
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

4.  Medullary thyroid carcinoma: multivariate analysis of prognostic factors influencing survival.

Authors:  Isabel Peixoto Callejo; José Américo Brito; Carlos Manuel Zagalo; Jorge Rosa Santos
Journal:  Clin Transl Oncol       Date:  2006-06       Impact factor: 3.405

5.  Strong expression of HBME-1 associates with high-risk clinicopathological factors of papillary thyroid carcinoma.

Authors:  Tijana M Isic Dencic; Svetlana B Savin; Sonja A Selemetjev; Svetlana D Paskas; Vladan R Zivaljevic; Vesna D Bozic; Dubravka S Cvejic
Journal:  Pathol Oncol Res       Date:  2015-01-11       Impact factor: 3.201

6.  Prognostic importance of histologic vascular invasion in papillary thyroid carcinoma.

Authors:  Laura Falvo; Antonio Catania; Vito D'Andrea; Antonella Marzullo; Maria Cristina Giustiniani; Enrico De Antoni
Journal:  Ann Surg       Date:  2005-04       Impact factor: 12.969

7.  Medullary thyroid carcinoma with micronodular lung metastases: a case report with an emphasis on the imaging findings.

Authors:  Nina Ventura; Edson Marchiori; Gláucia Zanetti; Antonio Muccillo; Mariana Leite Pereira; Guilherme Abdalla; Pedro Martins; Carolina Lamas Constantino; Rodrigo Canellas; Viviane Brandão; Romulo Varella de Oliveira
Journal:  Case Rep Med       Date:  2010-05-17

Review 8.  Medullary thyroid cancer.

Authors:  E Kebebew; O H Clark
Journal:  Curr Treat Options Oncol       Date:  2000-10

9.  Cytokeratin19 expression discriminates papillary thyroid carcinoma from other thyroid lesions and predicts its aggressive behavior.

Authors:  Tijana Isic Dencic; Dubravka Cvejic; Ivan Paunovic; Svetislav Tatic; Marija Havelka; Svetlana Savin
Journal:  Med Oncol       Date:  2012-12-27       Impact factor: 3.064

10.  Coexistence of chronic lymphocytic thyroiditis with papillary thyroid carcinoma: clinical manifestation and prognostic outcome.

Authors:  Jun Soo Jeong; Hyun Ki Kim; Cho-Rok Lee; Seulkee Park; Jae Hyun Park; Sang-Wook Kang; Jong Ju Jeong; Kee-Hyun Nam; Woong Youn Chung; Cheong Soo Park
Journal:  J Korean Med Sci       Date:  2012-07-25       Impact factor: 2.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.